OpenPV Signal Explorer
FAERS disproportionality dashboard
← All drugs
Drug

Ivermectin

289 flagged reaction(s) · 12,474 total co-reports · max PRR 19.1
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Encephalopathy 140 19.1 19.5 signal
2 Ocular Hyperaemia 257 18.4 19.2 signal
3 Coma 246 17.3 17.9 signal
4 Urinary Incontinence 136 15.4 15.7 signal
5 Hepatic Cytolysis 49 13.4 13.5 signal
6 Vertigo 218 11.9 12.3 signal
7 Anorexia 41 10.5 10.5 signal
8 Depressed Level Of Consciousness 123 10.4 10.6 signal
9 Dermatitis Contact 34 10.0 10.0 signal
10 Eosinophilia 50 9.6 9.6 signal
11 Product Prescribing Issue 58 9.5 9.6 signal
12 Rash Papular 61 9.1 9.1 signal
13 Eyelid Oedema 29 8.3 8.3 signal
14 Dermatitis Allergic 30 8.0 8.1 signal
15 Hepatocellular Injury 34 8.0 8.0 signal
16 Neurotoxicity 41 7.9 7.9 signal
17 Toxic Epidermal Necrolysis 35 7.7 7.8 signal
18 Drug Effective For Unapproved Indication 66 7.5 7.6 signal
19 Multiple Organ Dysfunction Syndrome 60 7.2 7.2 signal
20 Pain Of Skin 57 7.0 7.1 signal
21 Dermatitis 42 6.8 6.8 signal
22 Drug Reaction With Eosinophilia And Systemic Symptoms 50 6.5 6.6 signal
23 Product Use In Unapproved Indication 472 6.4 6.9 signal
24 Abnormal Behaviour 76 6.4 6.4 signal
25 Skin Irritation 84 6.1 6.2 signal
26 Aphasia 53 5.8 5.9 signal
27 Skin Burning Sensation 123 5.8 5.9 signal
28 Drug Ineffective For Unapproved Indication 95 5.7 5.8 signal
29 Asthenia 590 5.2 5.7 signal
30 Oral Discomfort 21 5.0 5.0 signal
31 Scab 17 5.0 5.0 signal
32 Rash Maculo-papular 33 5.0 5.0 signal
33 Altered State Of Consciousness 32 4.9 5.0 signal
34 Stevens-johnson Syndrome 33 4.9 5.0 signal
35 Covid-19 Pneumonia 17 4.8 4.8 signal
36 Acute Respiratory Distress Syndrome 25 4.7 4.7 signal
37 Pyrexia 485 4.7 5.0 signal
38 Peripheral Coldness 19 4.6 4.6 signal
39 Musculoskeletal Discomfort 23 4.5 4.5 signal
40 Septic Shock 57 4.4 4.4 signal
41 Incontinence 13 4.1 4.1 signal
42 Dysstasia 35 4.0 4.0 signal
43 Drug Administration Error 37 4.0 4.0 signal
44 Disorientation 47 3.9 4.0 signal
45 Nervous System Disorder 37 3.9 4.0 signal
46 Erythema 239 3.9 4.0 signal
47 Product Odour Abnormal 12 3.9 3.9 signal
48 Candida Infection 19 3.8 3.8 signal
49 Mental Status Changes 31 3.7 3.7 signal
50 Blood Pressure Abnormal 22 3.7 3.7 signal
51 Acute Respiratory Failure 21 3.7 3.7 signal
52 Ataxia 13 3.6 3.6 signal
53 Agranulocytosis 20 3.6 3.6 signal
54 Chromaturia 24 3.5 3.5 signal
55 Petechiae 11 3.5 3.5 signal
56 Ileus 13 3.5 3.5 signal
57 Generalised Oedema 13 3.5 3.5 signal
58 Headache 647 3.4 3.7 signal
59 Pruritus 388 3.4 3.6 signal
60 Agitation 75 3.4 3.4 signal
61 Face Oedema 17 3.3 3.3 signal
62 Skin Reaction 14 3.3 3.3 signal
63 Back Pain 229 3.3 3.4 signal
64 Secretion Discharge 12 3.2 3.2 signal
65 Poisoning Deliberate 9 3.2 3.2 signal
66 Application Site Erythema 25 3.2 3.2 signal
67 Vasculitis 11 3.1 3.1 signal
68 Swelling Face 61 3.1 3.1 signal
69 Conjunctivitis 17 3.1 3.1 signal
70 Disseminated Intravascular Coagulation 13 3.1 3.1 signal
71 Multi-organ Failure 16 3.0 3.0 signal
72 Application Site Pain 20 3.0 3.0 signal
73 Skin Exfoliation 75 3.0 3.0 signal
74 Cholestasis 17 3.0 3.0 signal
75 Intentional Product Misuse 77 3.0 3.0 signal
76 Speech Disorder 46 2.9 2.9 signal
77 Incorrect Drug Administration Duration 25 2.9 2.9 signal
78 Rash Erythematous 41 2.9 2.9 signal
79 Hyperbilirubinaemia 9 2.9 2.9 signal
80 Red Blood Cell Count Decreased 25 2.9 2.9 signal
81 Skin Disorder 29 2.9 2.9 signal
82 Chills 102 2.9 2.9 signal
83 Gait Disturbance 166 2.9 2.9 signal
84 Neck Pain 48 2.9 2.9 signal
85 Bacteraemia 10 2.8 2.8 signal
86 Clostridium Difficile Colitis 9 2.8 2.8 signal
87 Respiratory Failure 61 2.8 2.8 signal
88 Impaired Quality Of Life 12 2.8 2.8 signal
89 Expired Product Administered 27 2.7 2.7 signal
90 Lip Swelling 27 2.7 2.7 signal
91 Tachypnoea 11 2.7 2.7 signal
92 Hepatomegaly 8 2.7 2.7 signal
93 Malnutrition 9 2.7 2.7 signal
94 Rash Macular 28 2.7 2.7 signal
95 Ear Infection 21 2.6 2.6 signal
96 Electrolyte Imbalance 9 2.6 2.6 signal
97 Hepatitis 20 2.6 2.6 signal
98 Loss Of Consciousness 100 2.6 2.6 signal
99 Pruritus Generalised 17 2.6 2.6 signal
100 Scratch 8 2.6 2.6 signal
101 Myalgia 131 2.6 2.6 signal
102 Swollen Tongue 24 2.6 2.6 signal
103 Hepatic Failure 23 2.5 2.5 signal
104 Product Availability Issue 17 2.5 2.5 signal
105 Abasia 19 2.5 2.5 signal
106 Apathy 11 2.5 2.5 signal
107 Erythema Multiforme 7 2.5 2.5 signal
108 Drug Eruption 13 2.5 2.5 signal
109 Ocular Discomfort 8 2.5 2.5 signal
110 Skin Lesion 20 2.4 2.5 signal
111 Application Site Irritation 9 2.4 2.4 signal
112 Rash Pruritic 39 2.4 2.4 signal
113 Cytomegalovirus Infection 12 2.4 2.4 signal
114 Urinary Retention 24 2.4 2.4 signal
115 Vitreous Floaters 7 2.4 2.4 signal
116 Dry Skin 94 2.4 2.4 signal
117 Ascites 21 2.4 2.4 signal
118 Inappropriate Schedule Of Drug Administration 51 2.4 2.4 signal
119 Intentional Product Use Issue 62 2.3 2.4 signal
120 Adverse Event 64 2.3 2.3 signal
121 Dry Throat 7 2.3 2.3 no signal
122 Orthostatic Hypotension 12 2.3 2.3 signal
123 Eye Discharge 7 2.3 2.3 no signal
124 Immune System Disorder 9 2.3 2.3 signal
125 Feeling Cold 19 2.3 2.3 signal
126 Therapy Non-responder 30 2.2 2.2 signal
127 Application Site Pruritus 15 2.2 2.2 signal
128 Psychomotor Hyperactivity 11 2.2 2.2 signal
129 Osteopenia 10 2.2 2.2 signal
130 Sudden Death 7 2.2 2.2 no signal
131 Small Intestinal Obstruction 8 2.2 2.2 no signal
132 Urosepsis 6 2.2 2.2 no signal
133 Musculoskeletal Chest Pain 10 2.1 2.2 signal
134 Therapeutic Response Unexpected 29 2.1 2.2 signal
135 Blood Alkaline Phosphatase Increased 16 2.1 2.1 signal
136 Diarrhoea Haemorrhagic 6 2.1 2.1 no signal
137 Hypotension 127 2.1 2.1 signal
138 Pharyngeal Swelling 6 2.1 2.1 no signal
139 Head Discomfort 11 2.1 2.1 signal
140 Skin Haemorrhage 9 2.1 2.1 signal
141 Covid-19 110 2.1 2.1 signal
142 Dermatitis Atopic 31 2.1 2.1 signal
143 Sleep Disorder Due To A General Medical Condition 10 2.1 2.1 signal
144 Drug Ineffective 811 2.1 2.2 signal
145 Eating Disorder 13 2.0 2.0 signal
146 Alanine Aminotransferase Increased 37 2.0 2.0 signal
147 Eye Pain 33 2.0 2.0 no signal
148 Eye Swelling 22 2.0 2.0 no signal
149 Photophobia 11 2.0 2.0 no signal
150 Blister 33 2.0 2.0 no signal
151 Temperature Intolerance 6 2.0 2.0 no signal
152 Tooth Abscess 6 2.0 2.0 no signal
153 Liver Disorder 26 2.0 2.0 no signal
154 Drug Level Decreased 6 2.0 2.0 no signal
155 Drug Interaction 92 1.9 1.9 no signal
156 Application Site Rash 8 1.9 1.9 no signal
157 Off Label Use 500 1.9 2.0 no signal
158 Hereditary Angioedema 6 1.9 1.9 no signal
159 Prescribed Overdose 11 1.9 1.9 no signal
160 Hypercalcaemia 7 1.9 1.9 no signal
161 Paralysis 8 1.9 1.9 no signal
162 Eczema 28 1.9 1.9 no signal
163 Skin Laceration 6 1.8 1.9 no signal
164 Poisoning 7 1.8 1.8 no signal
165 Brain Fog 8 1.8 1.8 no signal
166 Infusion Site Pain 7 1.8 1.8 no signal
167 Photosensitivity Reaction 9 1.8 1.8 no signal
168 Respiratory Distress 15 1.8 1.8 no signal
169 Insurance Issue 8 1.8 1.8 no signal
170 Acne 41 1.8 1.8 no signal
171 Anhedonia 14 1.8 1.8 no signal
172 Heart Rate Increased 52 1.7 1.8 no signal
173 Scar 9 1.7 1.7 no signal
174 Sars-cov-2 Test Positive 7 1.7 1.7 no signal
175 Joint Range Of Motion Decreased 7 1.7 1.7 no signal
176 Skin Discolouration 24 1.7 1.7 no signal
177 Treatment Failure 42 1.7 1.7 no signal
178 Arthralgia 210 1.7 1.7 no signal
179 Hot Flush 38 1.7 1.7 no signal
180 Myoclonus 6 1.7 1.7 no signal
181 Respiratory Disorder 15 1.7 1.7 no signal
182 Vision Blurred 68 1.7 1.7 no signal
183 Lymphopenia 7 1.7 1.7 no signal
184 Product Use Issue 93 1.7 1.7 no signal
185 Sluggishness 5 1.6 1.6 no signal
186 Inappropriate Antidiuretic Hormone Secretion 5 1.6 1.6 no signal
187 Cyst 6 1.6 1.6 no signal
188 Incorrect Route Of Product Administration 8 1.6 1.6 no signal
189 Abdominal Pain Lower 12 1.6 1.6 no signal
190 Rash 205 1.6 1.6 no signal
191 Lacrimation Increased 14 1.6 1.6 no signal
192 Circulatory Collapse 8 1.6 1.6 no signal
193 Drug Resistance 12 1.6 1.6 no signal
194 Unresponsive To Stimuli 12 1.6 1.6 no signal
195 Product Prescribing Error 11 1.5 1.5 no signal
196 Hepatic Function Abnormal 17 1.5 1.5 no signal
197 Economic Problem 7 1.5 1.5 no signal
198 Cardio-respiratory Arrest 19 1.5 1.5 no signal
199 Pharyngeal Oedema 7 1.5 1.5 no signal
200 Eye Irritation 25 1.5 1.5 no signal
201 Hunger 6 1.5 1.5 no signal
202 Jaundice 12 1.5 1.5 no signal
203 Blindness 18 1.5 1.5 no signal
204 Rebound Effect 5 1.5 1.5 no signal
205 Intentional Dose Omission 12 1.5 1.5 no signal
206 Shock 10 1.5 1.5 no signal
207 Aphonia 6 1.4 1.4 no signal
208 Eye Pruritus 14 1.4 1.4 no signal
209 Abortion Induced 4 1.4 1.4 no signal
210 White Blood Cell Count Decreased 46 1.4 1.4 no signal
211 Feeling Hot 26 1.4 1.4 no signal
212 Cytokine Release Syndrome 8 1.4 1.4 no signal
213 Cytopenia 5 1.4 1.4 no signal
214 No Adverse Event 74 1.4 1.4 no signal
215 Electrocardiogram Qt Prolonged 15 1.4 1.4 no signal
216 Burning Sensation 29 1.4 1.4 no signal
217 Oral Herpes 8 1.4 1.4 no signal
218 Flushing 42 1.4 1.4 no signal
219 Seizure 47 1.4 1.4 no signal
220 Melaena 9 1.4 1.4 no signal
221 Hepatotoxicity 9 1.4 1.4 no signal
222 Disability 8 1.3 1.3 no signal
223 Salivary Hypersecretion 4 1.3 1.3 no signal
224 Brain Injury 4 1.3 1.3 no signal
225 Toxic Skin Eruption 4 1.3 1.3 no signal
226 Mydriasis 5 1.3 1.3 no signal
227 Folliculitis 4 1.3 1.3 no signal
228 Adverse Reaction 5 1.3 1.3 no signal
229 Intentional Overdose 24 1.3 1.3 no signal
230 Toxicity To Various Agents 63 1.2 1.3 no signal
231 Product Dose Omission In Error 10 1.2 1.2 no signal
232 Skin Fissures 7 1.2 1.2 no signal
233 Pneumonitis 10 1.2 1.2 no signal
234 Illness 37 1.2 1.2 no signal
235 Eructation 7 1.2 1.2 no signal
236 Inappropriate Schedule Of Product Administration 65 1.2 1.2 no signal
237 Acute Hepatic Failure 5 1.2 1.2 no signal
238 Mental Disorder 16 1.2 1.2 no signal
239 Product Packaging Quantity Issue 4 1.2 1.2 no signal
240 Alopecia 70 1.2 1.2 no signal
241 Myocarditis 4 1.2 1.2 no signal
242 Psoriatic Arthropathy 14 1.2 1.2 no signal
243 Overdose 75 1.2 1.2 no signal
244 Incorrect Product Administration Duration 7 1.1 1.1 no signal
245 Lactic Acidosis 11 1.1 1.1 no signal
246 Disease Recurrence 16 1.1 1.1 no signal
247 Muscle Rigidity 4 1.1 1.1 no signal
248 Breast Cancer Stage I 3 1.1 1.1 no signal
249 Anaphylactic Shock 8 1.0 1.0 no signal
250 Parkinsonism 3 1.0 1.0 no signal
251 Decreased Immune Responsiveness 3 1.0 1.0 no signal
252 Metastases To Bone 5 1.0 1.0 no signal
253 Accidental Overdose 11 1.0 1.0 no signal
254 Pneumocystis Jirovecii Pneumonia 3 1.0 1.0 no signal
255 Irritability 18 1.0 1.0 no signal
256 Circumstance Or Information Capable Of Leading To Medication Error 10 1.0 1.0 no signal
257 Angioedema 13 1.0 1.0 no signal
258 Poor Quality Product Administered 3 1.0 1.0 no signal
259 Therapeutic Response Shortened 9 0.9 0.9 no signal
260 Wrong Technique In Product Usage Process 56 0.9 0.9 no signal
261 Anosmia 4 0.9 0.9 no signal
262 Erectile Dysfunction 7 0.9 0.9 no signal
263 Drug Prescribing Error 5 0.9 0.9 no signal
264 Premature Delivery 4 0.8 0.8 no signal
265 Product Quality Issue 32 0.8 0.8 no signal
266 Myelosuppression 8 0.8 0.8 no signal
267 Tuberculosis 3 0.8 0.8 no signal
268 Complication Associated With Device 3 0.8 0.8 no signal
269 Extra Dose Administered 9 0.8 0.8 no signal
270 Hair Texture Abnormal 3 0.7 0.7 no signal
271 Incorrect Route Of Drug Administration 8 0.7 0.7 no signal
272 Product Administered At Inappropriate Site 4 0.7 0.7 no signal
273 Emotional Distress 25 0.7 0.7 no signal
274 Drug Exposure During Pregnancy 7 0.7 0.7 no signal
275 Product Physical Issue 4 0.7 0.7 no signal
276 Psoriasis 26 0.7 0.7 no signal
277 Product Preparation Error 4 0.6 0.6 no signal
278 Accidental Exposure To Product 19 0.6 0.6 no signal
279 Injection Site Mass 7 0.6 0.6 no signal
280 Bone Density Decreased 6 0.6 0.6 no signal
281 Suicide Attempt 11 0.6 0.6 no signal
282 Abortion Spontaneous 7 0.6 0.6 no signal
283 Palmar-plantar Erythrodysaesthesia Syndrome 4 0.6 0.6 no signal
284 Synovitis 3 0.6 0.6 no signal
285 Injection Site Urticaria 4 0.5 0.5 no signal
286 Foetal Exposure During Pregnancy 13 0.5 0.5 no signal
287 Exposure Via Skin Contact 3 0.4 0.4 no signal
288 Extrapyramidal Disorder 3 0.4 0.4 no signal
289 Renal Cancer 3 0.2 0.2 no signal